Crossmark

A retrospective analysis of medications associated with pityriasis rosea reported in the FDA adverse events reporting system

Published Online: 2025-01-13

Authors

Mashoudy, Kayla D. https://orcid.org/0000-0001-9577-5092
Ye-Tay, Joselyn

Nouri, Keyvan
License Information

Text and Data Mining valid from 2025-01-13

Version of Record valid from 2025-01-13
More Information

Article History

Received: 10 October 2024

Revised: 25 November 2024

Accepted: 20 December 2024

First Online: 13 January 2025

Declarations

:

: Since the FAERS database is openly accessible to the public and patient data is anonymized and de-identified, ethical clearance and informed consent are not required for this study.

: Not applicable.

: The authors declare no competing interests.

Document is current